The evaluation of metastatic lymph node ratio staging system in gastric cancer

Gastric Cancer

Volumn 16, Issue 3, 2013, Pages 309-317

  Zhou, Yanbing ^a   Zhang, Jizhun ^a   Cao, Shougen ^a   Li, Yu ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Gastric cancer; Lymph node; Staging

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH SURGERY; SURVIVAL RATE; SURVIVAL TIME;

EID: 84880818917     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0190-1     Document Type: Article

References (25)

1. Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics 2011. CA Cancer J Clin. 2011;61:69-90.
2. Manfe AZ, Segalina P, Maffei Faccioli A. Prognostic factors in gastric cancer. Our experience and review of the literature. Minerva Chir. 2000;55:299-305.
3. Greene FL, Page DL, Fleming ID. AJCC cancer staging manual: TNM classification of malignant tumors. 6th ed. New York: Springer; 2002.
4. Edge SB, Byrd DR, Compton CC. AJCC cancer staging handbook. 7th ed. New York: Springer; 2010.
5. Estes NC, MacDonald JS, Touijer K, Benedetti J, Jacobson J. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am Surg. 1998;64:680-5.
6. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-30.
7. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828-35.
8. Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer (Phila). 2006;107:2143-51.
9. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-84.
10. Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy. Ann Surg. 2011;00:1-9.
11. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-8.
12. Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, et al. Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer (Phila). 2010;11:5592-8.
13. Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American joint committee on cancer TNM staging system for gastric cancer. Cancer (Phila) 2011 (Epub ahead of print).
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer. 1998;1:10-24.
15. Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol. 2009;16:1868-74.
16. Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, et al. Long positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-26.
17. Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-77.
18. Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;1:27-35.
19. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy. Ann Surg. 2007;245:543-52.
20. Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91.
21. Wang X, Wan F, Wang J. A common misuse of stepwise regression in studies of ratio of metastatic lymph nodes for gastric cancer. Ann Surg Oncol. 2008;15:1805-6.
22. Kulig J, Sierzega M, Kolodziejczyk P, Popiela T. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg. 2009;96:910-8.
23. Persiani R, Rausei S, Antonacci V, Biondi A, Casella F, Ciccoritti L, et al. Metastatic lymph node ratio: a new staging system for gastric cancer. World J Surg. 2009;33:2106-11.
24. Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, et al. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol. 2009;20:897-905.
25. Wang W, Xu DZ, Li YF, Guan YX, Sun XW, Chen YB, et al. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection - results of a single institution study of 1343 Chinese patients. Ann Oncol. 2011;22:2049-56.